Antibiotic Dosing in Pediatric Intensive Care
Recruiting
Observational Study
Pharmacokinetics
Amoxicillin-clavulanate
Piperacillin-tazobactam
Vancomycin
Teicoplanin
Meropenem
Ciprofloxacin
Amikacin
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Day – 16
- Sex
- Any
- Study type
- Observational
- Participants needed
- 640 (estimated)
- Sponsor
- University Hospital, Ghent · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pharmacokinetics of antibiotics in critically ill neonates, infants and children
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients admitted to the pediatric intensive care unit
* patient age/weight : 1,8 kg-15 years
* patient receiving antibiotic treatment (piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, teicoplanin, meropenem, ciprofloxacin, amikacin) via intermittent infusion regi…
Contacts